12-49188874-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001270399.2(TUBA1A):c.-455C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0482 in 1,612,362 control chromosomes in the GnomAD database, including 2,275 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 127 hom., cov: 32)
Exomes 𝑓: 0.049 ( 2148 hom. )
Consequence
TUBA1A
NM_001270399.2 5_prime_UTR
NM_001270399.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.991
Genes affected
TUBA1A (HGNC:20766): (tubulin alpha 1a) Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulins. The genes encoding these microtubule constituents belong to the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes, which are highly conserved among species. This gene encodes alpha tubulin and is highly similar to the mouse and rat Tuba1 genes. Northern blot studies have shown that the gene expression is predominantly found in morphologically differentiated neurologic cells. This gene is one of three alpha-tubulin genes in a cluster on chromosome 12q. Mutations in this gene cause lissencephaly type 3 (LIS3) - a neurological condition characterized by microcephaly, intellectual disability, and early-onset epilepsy caused by defective neuronal migration. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
TUBA1C (HGNC:20768): (tubulin alpha 1c) Predicted to enable GTP binding activity. Predicted to be a structural constituent of cytoskeleton. Predicted to be involved in microtubule cytoskeleton organization and mitotic cell cycle. Located in microtubule cytoskeleton and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-49188874-G-A is Benign according to our data. Variant chr12-49188874-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1207784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0531 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBA1A | NM_006009.4 | c.3+103C>T | intron_variant | Intron 1 of 3 | ENST00000301071.12 | NP_006000.2 | ||
TUBA1A | NM_001270399.2 | c.-455C>T | 5_prime_UTR_variant | Exon 1 of 4 | NP_001257328.1 | |||
TUBA1A | NM_001270400.2 | c.-103+15C>T | intron_variant | Intron 1 of 3 | NP_001257329.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0367 AC: 5576AN: 152126Hom.: 127 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5576
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0495 AC: 72210AN: 1460118Hom.: 2148 Cov.: 33 AF XY: 0.0486 AC XY: 35287AN XY: 726368 show subpopulations
GnomAD4 exome
AF:
AC:
72210
AN:
1460118
Hom.:
Cov.:
33
AF XY:
AC XY:
35287
AN XY:
726368
Gnomad4 AFR exome
AF:
AC:
297
AN:
33468
Gnomad4 AMR exome
AF:
AC:
1460
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
549
AN:
26136
Gnomad4 EAS exome
AF:
AC:
2
AN:
39698
Gnomad4 SAS exome
AF:
AC:
637
AN:
86252
Gnomad4 FIN exome
AF:
AC:
2012
AN:
51820
Gnomad4 NFE exome
AF:
AC:
64289
AN:
1111888
Gnomad4 Remaining exome
AF:
AC:
2751
AN:
60364
Heterozygous variant carriers
0
4563
9126
13690
18253
22816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2362
4724
7086
9448
11810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0366 AC: 5574AN: 152244Hom.: 127 Cov.: 32 AF XY: 0.0363 AC XY: 2701AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
5574
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
2701
AN XY:
74438
Gnomad4 AFR
AF:
AC:
0.0109753
AN:
0.0109753
Gnomad4 AMR
AF:
AC:
0.0475069
AN:
0.0475069
Gnomad4 ASJ
AF:
AC:
0.0195965
AN:
0.0195965
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00601161
AN:
0.00601161
Gnomad4 FIN
AF:
AC:
0.0439623
AN:
0.0439623
Gnomad4 NFE
AF:
AC:
0.0545754
AN:
0.0545754
Gnomad4 OTH
AF:
AC:
0.0439509
AN:
0.0439509
Heterozygous variant carriers
0
279
558
838
1117
1396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 05, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at